Kynam Capital Management, LP Global Blood Therapeutics, Inc. Transaction History

Kynam Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $67 Million - $141 Million	-2,068,780 Reduced 94.04%	131,220 $8.94 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $19.2 Million - $32.2 Million	860,678 Added 64.26%	2,200,000 $70.3 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $8.89 Million - $12.3 Million	346,373 Added 34.88%	1,339,322 $46.4 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $24.7 Million - $40 Million	992,949 New	992,949 $29.1 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.